Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 100,749 |
|
|||||
| News | - | ||||||
| Day High | 11.53 | Low High |
|||||
| Day Low | 9.61 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| FibroBiologics Inc | FBLG | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -1.57 | -13.44% | 10.11 | 18:14:42 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 11.53 | 9.61 | 11.53 | 10.11 | 11.68 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,295 | 100,749 | $ 10.15 | $ 1,022,108 | - | 6.53 - 55.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:52:36 | 2 | $ 9.70 | USD |
FibroBiologics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 329.61M | 32.63M | - | 0 | -19.06M | -0.58 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
FibroBiologics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical FBLG Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 11.11 | 11.70 | 9.61 | 11.11 | 43,293 | -1.00 | -9.00% |
| 1 Month | 10.83 | 11.88 | 9.185 | 10.86 | 68,917 | -0.72 | -6.65% |
| 3 Months | 13.73 | 19.60 | 6.53 | 12.18 | 95,434 | -3.62 | -26.37% |
| 6 Months | 30.00 | 55.00 | 6.53 | 12.55 | 97,761 | -19.89 | -66.30% |
| 1 Year | 30.00 | 55.00 | 6.53 | 12.55 | 97,761 | -19.89 | -66.30% |
| 3 Years | 30.00 | 55.00 | 6.53 | 12.55 | 97,761 | -19.89 | -66.30% |
| 5 Years | 30.00 | 55.00 | 6.53 | 12.55 | 97,761 | -19.89 | -66.30% |
FibroBiologics Description
| FibroBiologics, Inc. operates as a clinical-stage cell therapy company that focuses on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs. The company develops CybroCell for degenerative disc disease; CYMS101 to treat multiple sclerosis; and CYWC628 for treating wound healing. Its early-stage research programs include CYTER915 which is designed to regenerate or reinvigorate production of the thymus and/or spleen; and TCB190 for the treatment of cancers. The company was incorporated in 2021 and is based in Houston, Texas. FibroBiologics, Inc. operates as a subsidiary of Spinalcyte Llc. |
